CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis

BACKGROUND: CFTR modulators decrease some etiologies of CF airway inflammation; however, data indicate that non-resolving airway infection and inflammation persist in individuals with CF and chronic bacterial infections. Thus, identification of therapies that diminish airway inflammation without all...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Main Authors: Hisert, Katherine B., Birkland, Timothy P., Schoenfelt, Kelly Q., Long, Matthew E., Grogan, Brenda, Carter, Suzanne, Liles, W. Conrad, McKone, Edward F., Becker, Lev, Manicone, Anne M., Gharib, Sina A.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7461946/
https://ncbi.nlm.nih.gov/pubmed/33013356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01219
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares